<DOC>
	<DOCNO>NCT00811655</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiosurgery may able send x-ray directly tumor cause less damage normal tissue . Giving stereotactic radiosurgery surgery may make tumor small reduce amount normal tissue need remove . PURPOSE : This phase II trial study well stereotactic radiosurgery work treat patient brain metastasis .</brief_summary>
	<brief_title>Stereotactic Radiosurgery Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : Primary - To estimate rate recurrence surgical site patient brain metastasis treat neoadjuvant stereotactic radiosurgery ( SRS ) compare historical data document recurrence surgical site surgical resection whole-brain radiotherapy ( WBRT ) . Secondary - To estimate rate salvage WBRT , SRS , surgery patient treat neoadjuvant SRS alone . - To determine volume adjacent normal brain parenchyma irradiated patient . - To estimate rate new brain metastasis outside neoadjuvant SRS site patient . - To estimate quality life patient neoadjuvant SRS alone . - To assess effect SRS surgical intervention preservation neurocognitive functioning patient . - To determine clinical significance ( mass effect , cognitive functioning , symptom ) locally recurrent brain metastasis time occurrence patient . - To estimate rate death due neurologic cause , define death attributable progression neurological disease , patient . - To estimate overall survival patient . OUTLINE : Patients undergo stereotactic radiosurgery 30 90 minute . Approximately 2-4 week later , patient undergo surgical resection brain metastasis . Quality life neurocognitive function assess periodically use FACT-Br subscales Mini-Mental State Exam . After completion study treatment , patient follow every 3 month 1 year every 6 month 1 year .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis brain metastases extracranial primary site Tumor â‰¤ 4 cm maximal extent plane contrast MRI Scheduled undergo gross total resection single brain metastasis confirm histology Up 4 metastasis allow provide large mass amenable surgical resection nonresected mass amenable stereotactic radiosurgery ( SRS ) RTOG Recursive Partitioning Analysis ( RPA ) class 1 2 , define follow : RPA class 1 : Karnofsky performance status ( KPS ) 70100 % ; age &lt; 65 year ; control primary disease ; extracranial metastatic disease RPA class 2 : KPS 70100 % ; uncontrolled primary disease ; and/or extracranial metastatic disease No lesion locate anatomic region amenable SRS , include brain stem , optic apparatus , eloquent cortex No primary lesion radiosensitive histology ( e.g. , small cell carcinoma , germ cell tumor , lymphoma , leukemia , multiple myeloma ) No radiographic cytologic evidence leptomeningeal disease PATIENT CHARACTERISTICS : See Disease Characteristics Not pregnant nursing Negative pregnancy test No concurrent uncontrolled illness include , limited , follow : Symptomatic congestive heart failure Unstable angina pectoris Psychiatric illness No contraindication SRS , wholebrain radiotherapy , MRI PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior brain surgery resection metastasis No prior brain radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>tumor metastatic brain</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>